Ibrutinib is a targeted therapy used to treat certain B-cell cancers like mantle cell lymphoma and chronic lymphocytic leukemia. This compound is essential for the synthesis of the active pharmaceutical ingredient (API) Ibrutinib, and is also used in related laboratory research and development. 3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine is used mainly as a synthetic intermediate in the production of the drug Ibrutinib.
3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine
| API Name | Ibrutinib |
|---|---|
| CAS No | 330786-24-8 |
| Molecular Formula | C17H13N5O |
| Molecular Weight | 303.32 g/mol |
| Synonyms | 3-(4-phenoxyphenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-amine |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
Ibrutinib is a targeted therapy used to treat certain B-cell cancers like mantle cell lymphoma and chronic lymphocytic leukemia. This compound is essential for the synthesis of the active pharmaceutical ingredient (API) Ibrutinib, and is also used in related laboratory research and development. 3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine is used mainly as a synthetic intermediate in the production of the drug Ibrutinib.
The CAS number of 3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine is 330786-24-8.
The molecular formula of 3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine is C17H13N5O.
The listed molecular weight of 3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine is 303.32 g/mol.
3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine is listed as being used in connection with the following API: Ibrutinib.
The listed synonym or IUPAC name for 3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine is 3-(4-phenoxyphenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-amine.